- Product
- Eventually, Fulcare’s YouTube Ad is deleted
- by Jung, Heung-Jun Jul 20, 2020 06:18am
- When Mennarini Korea's athlete's foot drug Fulcare’s YouTube advertisement raised a problem saying that Ads excluded pharmacist skills, the pharmaceutical company deleted the video and began to rectify it. The content of the controversial advertisement is a scene where Another patient who was waiting for a patient who visited the pharmac
- Product
- Will electronic masks by LG be commercialized?
- by Kang, Shin-Kook Jul 15, 2020 06:33am
- Electronic masks made by famous domestic home appliance companies are attracting attention. LG Electronics announced on the 12th that it has donated 2000 electronic masks made of electronics and IT technology to Severance Hospital to express appreciation and support to medical staff who need to work while wearing masks to overcome COVID-19.
- Product
- Why Tylenol short in pharmacy, but still plenty in GS25?
- by Jung, Heung-Jun Jun 18, 2020 06:27am
- Pharmacies in Korea are experiencing a long-term shortage of Tylenol 500 mg and Tylenol ER 600 mg, but apparently convenient stores have no issue stocking up Tylenol 500 mg. As of June 15, Tylenol in 500 mg and ER 650 mg tablets were indicated to be sold out on an online pharmaceutical wholesale website used by pharmacists. Since the
- Product
- Metformin's alternative medicine sold out in an hour
- by Kim JiEun May 29, 2020 06:16am
- As the discontinuation of sales of 31 items of Metformin used as a treatment for type II diabetes patients is decided, the shortage of alternative products is intensifying. The MFDS announced that it will temporarily manufacture, sell, and discontinue prescriptions for 31 items containing Metformin, which are used as a primary treatment for t
- Product
- KDA “Agree with government action on metformin with NDMA”
- by An, Kyung-Jin May 28, 2020 10:07am
- Medical academic societies expressed their support for the Korean government’s decision to suspend manufacturing and sales of metformin with excessive level of impurity found. However, the scholars noted diabetic patients should not stop taking metformin without consulting their doctors. On May 26, Korean Diabetes Association (KDA) and Kore
- Product
- Hospitals ready to prescribe another CDK inhibitor Kisqali
- by Eo, Yun-Ho May 21, 2020 06:01am
- Following after Ibrance and Verzenio, a third cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitor is landing its prescription code in Korean general hospitals. Pharmaceutical industry sources reported drug committees at eight major general hospitals like Seoul National University Hospital, Seoul Asan Medical Center, National Cancer Center
- Product
- Fexuprazan taking over K-CAB market? Study unveiled
- by choi, sun May 11, 2020 06:15am
- As Daewoong Pharmaceutical unveiled Phase III clinical data of its next-generation gastroesophageal reflux disease agent in development, fexuprazan, the Korean pharmaceutical industry is keeping a close eye on the prospective competition between the existing proton pump inhibitors (PPI) tegoprazan (Brand name: K-CAB) and the novel agent. Reve
- Product
- The KPA, criticized the MFDS/the Regulatory Reform Committee
- by Kang, Shin-Kook May 6, 2020 06:32am
- The Korean Pharmaceutical Association (KPA) strongly objected to the withdrawal of step-by-step abolition policy for generic co-biological equivalence testing. On the 28th, the Korean Pharmaceutical Association (Chairman Dae-up Kim) announced that the Regulatory Reform Committee recommended the withdrawal of the amendment to the 'Regulatio
- Product
- Imported drugs are out of stock due to COVID-19 crisis
- by Kim, Min-Gun Apr 9, 2020 06:27am
- Difficulties in supplying medical products are also continuing in the aftermath of COVID-19, which hit Europe. According to the distribution industry on the 7th, domestic and foreign pharmaceutical companies, such as Kuhnil Pharmaceutical, Daewoong Pharmaceutical, JW Pharmaceutical, and Pfizer Korea, stopped supply due to delays in the pro
- Product
- Disaster subsidies must be paid to all citizens
- by Jung, Heung-Jun Apr 9, 2020 06:26am
- 9 out of 10 Dailypharm readers expressed their opinion that the government's emergency disaster aid under COVID-19 should be paid to the entire population, not just the bottom 70% of income. Dailypharm conducted an opinion poll on how to pay for emergency disaster aid through the online survey of Issue & Poll from the 1st to the 7th.
